Published in Am J Med Genet on May 28, 1999
Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci U S A (2001) 2.09
Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res (2006) 1.47
Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues. Hum Mol Genet (2010) 1.46
Instability and chromatin structure of expanded trinucleotide repeats. Trends Genet (2009) 1.36
The DNA replication program is altered at the FMR1 locus in fragile X embryonic stem cells. Mol Cell (2013) 1.16
Role of replication and CpG methylation in fragile X syndrome CGG deletions in primate cells. Am J Hum Genet (2004) 1.06
Potential therapeutic interventions for fragile X syndrome. Trends Mol Med (2010) 1.05
Cis-acting DNA sequence at a replication origin promotes repeat expansion to fragile X full mutation. J Cell Biol (2014) 0.86
The transcription-coupled repair protein ERCC6/CSB also protects against repeat expansion in a mouse model of the fragile X premutation. Hum Mutat (2015) 0.82
Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders. Front Genet (2014) 0.82
The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome. Int J Physiol Pathophysiol Pharmacol (2012) 0.78
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med (1996) 7.66
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A (1997) 4.73
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet (2002) 4.00
Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet (2001) 3.82
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet (2001) 3.77
A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet (1993) 3.58
Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord (1991) 3.37
Nonthrombotic pulmonary embolism. Eur Respir J (2009) 2.93
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron (2005) 2.82
Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet (1997) 2.82
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer (2002) 2.82
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (1990) 2.80
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology (1999) 2.74
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? Trans R Soc Trop Med Hyg (2002) 2.63
Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology (2007) 2.51
The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat Genet (1993) 2.47
Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex. EMBO J (1988) 2.44
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40
Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature (1993) 2.36
Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet (1997) 2.27
FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet (1999) 2.23
Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet (1994) 2.19
Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem (1993) 2.18
Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol (1991) 2.08
Non-syndromic, autosomal-recessive deafness. Clin Genet (2006) 2.08
Thrombolysis in cervical artery dissection--data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database. Eur J Neurol (2012) 2.07
The fragile X syndrome. J Med Genet (1998) 2.00
The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci U S A (1993) 1.99
Meta-analysis of genome-wide association studies for personality. Mol Psychiatry (2010) 1.96
Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol (1992) 1.95
Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry (2007) 1.93
ACE polymorphisms. Circ Res (2006) 1.92
Deletion loop mutagenesis: a novel method for the construction of point mutations using deletion mutants. Nucleic Acids Res (1982) 1.90
POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology (2004) 1.89
High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet (1999) 1.87
Early diagnosis of cerebral fat embolism syndrome by diffusion-weighted MRI (starfield pattern). Stroke (2001) 1.86
Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J (1994) 1.85
The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain (1999) 1.84
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet (2001) 1.83
Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis. Hum Mol Genet (1993) 1.82
Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer (1999) 1.81
A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet (1992) 1.80
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia (2000) 1.80
Familial aggregation in frontotemporal dementia. Neurology (1998) 1.76
A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes (2001) 1.76
Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J Biol Chem (1984) 1.75
Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet (1997) 1.74
Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res (2000) 1.73
Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet (2001) 1.71
Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord (2003) 1.70
CGG repeat in the FMR1 gene: size matters. Clin Genet (2011) 1.68
Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum Mol Genet (1994) 1.68
Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families. Nature (1987) 1.68
Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet (1993) 1.68
A new family with the Townes-Brocks syndrome. Clin Genet (1988) 1.66
Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer (1998) 1.64
CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet (1995) 1.64
Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet (1998) 1.63
Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet (1995) 1.63
Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet (1992) 1.62
Mitochondrial deafness. Clin Genet (2007) 1.61
MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology (2009) 1.61
Shared genetic factors in migraine and depression: evidence from a genetic isolate. Neurology (2010) 1.61
Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet (1997) 1.59
Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am J Hum Genet (2000) 1.59
Estimating human age from T-cell DNA rearrangements. Curr Biol (2010) 1.58
Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet (1996) 1.58
Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol (2001) 1.57
A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology (1993) 1.57
Mental status of females with an FMR1 gene full mutation. Am J Hum Genet (1996) 1.57
Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group. J Med Genet (1992) 1.57
L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patterns. Hum Mol Genet (1998) 1.54
Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet (1999) 1.54
Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum Mol Genet (1999) 1.53
Congenital diaphragmatic hernia and chromosome 15q26: determination of a candidate region by use of fluorescent in situ hybridization and array-based comparative genomic hybridization. Am J Hum Genet (2005) 1.52
Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis. Nature (1983) 1.52
Molecular dissection of a contiguous gene syndrome: localization of the genes involved in the Langer-Giedion syndrome. Hum Mol Genet (1995) 1.51
Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry (2010) 1.50
Cystosarcoma phyllodes of the prostate with rhabdomyoblastic differentiation. Pathol Res Pract (2001) 1.49
FMRP is associated to the ribosomes via RNA. Hum Mol Genet (1996) 1.49
Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum Mol Genet (1997) 1.49
Poor outcome in Down syndrome fetuses with cardiac anomalies or growth retardation. Am J Med Genet A (2003) 1.48
Magnetic resonance imaging in the evaluation of patients with eosinophilic fasciitis. J Rheumatol (1989) 1.48
Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res (2006) 1.47